2016年 9月 7日
Apple has published updated guidelines for how the company reviews applications submitted for sale via its App Store, with an expanded section focused on safety requirements for health and medical apps.
Under a longer “Physical Harm” section, the guidelines provide several examples of user risk issues that may lead to rejection of an app.
Developers submitting such apps for review should also ensure that their support contact details and Wallet passes are up to date and maintained regularly.
Although the FDA has issued its own guidance on mobile medical and health apps, Apple’s latest recommendations also warrant careful attention from developers since the App Store serves as a major access point for these tools.
For more information on US regulatory requirements for mobile medical technologies, download our whitepaper on the topic.